Related Experiment Videos
A novel candidate oncogene, MCT-1, is involved in cell cycle progression
M Prosniak1, J Dierov, K Okami
1Center for NeuroVirology and NeuroOncology, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania 19102, USA.
Cancer Research
|October 10, 1998
Summary
A novel gene, MCT-1, was identified and found to be overexpressed in T-cell malignancies. This gene promotes cell proliferation and transformation, suggesting it is a candidate oncogene involved in cancer development.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Genetic abnormalities in lymphoid cell lines can indicate disease mechanisms.
- Novel genes play crucial roles in cellular processes and disease.
Purpose of the Study:
- To identify and characterize a novel gene, MCT-1, involved in T-cell malignancies.
- To investigate the functional role of MCT-1 in cell cycle regulation and transformation.
Main Methods:
- Arbitrarily primed-PCR (AP-PCR) assay for genetic abnormality detection.
- Northern blot analysis and cDNA sequencing for gene characterization.
- Fluorescence in situ hybridization (FISH) for gene localization.
- Cell proliferation and soft agar growth assays to assess functional role.
Main Results:
- A novel gene, MCT-1, was identified and found to be amplified in T-cell malignancies.
- MCT-1 showed low-level expression in normal human tissues but was overexpressed in cancer.
- MCT-1 shares limited homology with cyclin H, suggesting a role in cell cycle regulation.
- Overexpression of MCT-1 increased cell proliferation by shortening the G1 phase.
- MCT-1 overexpression conferred transforming ability to cells in soft agar assays.
Conclusions:
- MCT-1 is a novel candidate oncogene implicated in T-cell malignancies.
- MCT-1's homology to cyclin H suggests a role in cell cycle regulation.
- MCT-1 overexpression drives cell proliferation and transformation, contributing to cancer development.